ALPEK, S.A.B. de C.V.

DB:27A Stock Report

Market Cap: €903.9m

ALPEK. de Valuation

Is 27A undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Future Cash Flow Value

What is the Fair Price of 27A when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Fair Value: 27A (€0.39) is trading below our estimate of fair value (€1.32)

Significantly Below Fair Value: 27A is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 27A?

Key metric: As 27A is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 27A. This is calculated by dividing 27A's market cap by their current revenue.
What is 27A's PS Ratio?
PS Ratio0.1x
SalesMex$133.75b
Market CapMex$18.78b

Price to Sales Ratio vs Peers

How does 27A's PS Ratio compare to its peers?

The above table shows the PS ratio for 27A vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.1x
SIM0 SIMONA
0.5xn/a€303.0m
FPE3 Fuchs
1.5x3.14%€4.6b
IBU IBU-tec advanced materials
2.4x26.16%€112.1m
7M8 EcoRub
0.08xn/a€57.3m
27A ALPEK. de
0.1x2.77%€18.8b

Price-To-Sales vs Peers: 27A is good value based on its Price-To-Sales Ratio (0.1x) compared to the peer average (1.1x).

Historical Price to Sales Ratio

Historical Price to Sales Ratio compares a stock's price to its sales over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Sales Ratio vs Industry

How does 27A's PS Ratio compare vs other companies in the DE Chemicals Industry?

2 CompaniesPrice / SalesEstimated GrowthMarket Cap
7M8 EcoRub
0.08xn/aUS$66.69m
B7Y Byotrol
0.04xn/aUS$246.97k
No more companies available in this PS range
27A 0.1xIndustry Avg. 1.1xNo. of Companies3PS00.40.81.21.62+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 27A is good value based on its Price-To-Sales Ratio (0.1x) compared to the European Chemicals industry average (1.1x).

Price to Sales Ratio vs Fair Ratio

What is 27A's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

27A PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.1x
Fair PS Ratio0.2x

Price-To-Sales vs Fair Ratio: 27A is good value based on its Price-To-Sales Ratio (0.1x) compared to the estimated Fair Price-To-Sales Ratio (0.2x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 27A forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€0.39
€0.66
+71.26%
18.86%€0.91€0.48n/a12
Jan ’27€0.43
€0.65
+52.79%
18.86%€0.90€0.47n/a12
Dec ’26€0.39
€0.67
+73.32%
17.92%€0.89€0.47n/a12
Nov ’26€0.42
€0.67
+58.13%
17.92%€0.89€0.47n/a12
Oct ’26€0.45
€0.67
+49.88%
18.54%€0.88€0.46n/a12
Sep ’26€0.39
€0.67
+70.78%
18.54%€0.87€0.46n/a12
Aug ’26€0.38
€0.68
+79.41%
16.13%€0.87€0.55n/a12
Jul ’26€0.45
€0.71
+58.75%
18.25%€0.95€0.54n/a12
Jun ’26€0.50
€0.71
+41.66%
16.11%€0.91€0.55n/a12
May ’26€0.43
€0.69
+61.59%
16.11%€0.89€0.54n/a12
Apr ’26€0.46
€0.81
+75.09%
17.11%€1.05€0.59n/a12
Mar ’26€0.59
€0.83
+41.45%
15.75%€1.08€0.61n/a12
Feb ’26€0.67
€0.89
+33.27%
19.49%€1.26€0.61n/a12
Jan ’26€0.61
€0.89
+45.46%
20.10%€1.28€0.61€0.4312
Dec ’25€0.61
€0.93
+50.60%
33.42%€1.69€0.50€0.3911
Nov ’25€0.58
€0.92
+59.12%
34.21%€1.70€0.51€0.4211
Oct ’25€0.56
€0.88
+57.22%
35.88%€1.67€0.50€0.4511
Sep ’25€0.56
€0.98
+76.35%
35.08%€1.84€0.55€0.3911
Aug ’25€0.59
€0.98
+64.49%
35.08%€1.84€0.55€0.3811
Jul ’25€0.66
€0.99
+51.53%
35.50%€1.89€0.56€0.4511
Jun ’25€0.76
€1.06
+40.66%
35.67%€2.01€0.60€0.5011
May ’25€0.68
€1.06
+56.48%
38.50%€2.02€0.60€0.4310
Apr ’25€0.67
€1.12
+67.07%
32.72%€2.04€0.61€0.4612
Mar ’25€0.58
€1.15
+98.12%
28.41%€2.01€0.70€0.5912
Feb ’25€0.61
€1.25
+104.72%
26.60%€2.00€0.81€0.6712
Jan ’25€0.67
€1.20
+80.70%
29.44%€1.98€0.75€0.6112
€0.6
Fair Value
35.8% undervalued intrinsic discount
12
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/13 10:41
End of Day Share Price 2026/01/13 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

ALPEK, S.A.B. de C.V. is covered by 20 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Pablo Monsivais MendozaBarclays
Gilberto GarciaBarclays
Leonardo MarcondesBofA Global Research